News View Non-AMP

MicroStrategy in the News: South Korea’s NPS and New ETF MSTX Fuel Bitcoin Rally

Published by
Nidhi Kolhapur

South Korea’s National Pension Scheme (NPS), one of the world’s largest pension funds, has made a surprising strategic move. The pension giant disclosed a substantial purchase of 245,000 MicroStrategy (MSTR) shares during the second quarter as per the latest 13F filing submitted to the SEC. The MSTR stock price is up 92% year to date, while most of the gains came in the first quarter of this year.

The NPS’s total outlay for MSTR shares amounts to 46 billion won, or approximately $33.7 million. This investment represents just 0.04% of the NPS’s direct U.S. stock portfolio, highlighting a strategic allocation in a high-performing asset.

Expanding Into Crypto

In the third quarter of 2023, the NPS also made headlines by acquiring a substantial 282,673 shares of coinbase (COIN), marking its entry into the cryptocurrency sector. Since then, COIN’s share price has surged from $78 to $222 by the end of the second quarter, reflecting a remarkable 3x increase. Notably, microstrategy , known for being the largest corporate holder of Bitcoin, currently owns over 1% of the total Bitcoin supply.

New ETF on the Horizon!

Adding to the excitement, Sylvia Jablonski, CEO of Defiance ETFs, announced the SEC’s approval of MSTX, the first leveraged single-stock ETF focused on MicroStrategy. The fund, which began trading on August 15, aims to deliver 175% daily targeted exposure to MicroStrategy’s stock performance.

High-Risk, High-Reward Opportunity

MSTX offers investors a high-risk, high-reward opportunity, providing leveraged exposure to MicroStrategy’s stock and, indirectly, to Bitcoin. According to Jablonski,

“Given MicroStrategy’s inherent higher beta than Bitcoin, MSTX offers a unique opportunity for investors to maximize their leverage exposure to the Bitcoin market within an ETF wrapper.”

This ETF allows investors to gain leveraged exposure to MicroStrategy’s stock without needing a margin account, potentially amplifying both returns and risks tied to Bitcoin’s performance. However, Defiance ETFs cautions that MSTX is intended for sophisticated investors who actively manage their portfolios.

It’s a Bumpy Road Ahead

Eric Balchunas, Senior ETF Analyst at Bloomberg, recently highlighted that Defiance ETFs’ 1.75x leveraged MicroStrategy ETF ($MSTX) is poised to become one of the most volatile ETFs in the U.S. market.

Also Check Out: Crypto Regulations in South Korea 2024

With the launch of MSTX, investors now have a new avenue to gain exposure to Bitcoin, albeit with increased risk. Will it be worth it? Time will tell.

Nidhi Kolhapur

Nidhi is a Certified Digital Marketing Executive and Passionate crypto Journalist covering the world of alternative currencies. She shares the latest and trending news on Cryptocurrency and Blockchain.

Recent Posts

Bitcoin Price Prediction 2025: Here’s Why You Need Not Panic as BTC Price May Rebound Soon!

Bitcoin is about to close the monthly trade on a bearish note, which may hinder…

March 30, 2025

Shiba Inu Price Prediction: SHIB Flashes Green As Rexas Finance (RXS) Positions Itself For a Shocking 21450% Move

Shiba Inu(SHIB) has been making headlines, especially with its recent development. It has started flashing…

March 30, 2025

Missed Solana’s 10,000% Run? These 4 Tiny Coins Could Turn $250 Into $1 Million by June 2025

Solana experienced an extraordinary surge, leaving many wishing they had invested sooner. Now, four small…

March 30, 2025

Ethereum Loses an Important Support—Is ETH Price Heading Back to $1500?

The crypto markets have been facing a massive pullback over the past couple of days,…

March 30, 2025

Bitcoin, Ethereum, and XRP Price Prediction Next Week: Will the Crypto Market’s Downturn Hold?

The last few days of March have brought a sharp decline to the crypto market.…

March 30, 2025

Bitcoin Price Battles to Stay Above $83k, Is the Rally Done?

Bitcoin (BTC) is facing increasing pressure as key support levels are breaking, raising concerns about…

March 30, 2025